Literature DB >> 21920674

Neuropsychological deficits associated with cannabis use in young adults.

Jon E Grant1, Samuel R Chamberlain, Liana Schreiber, Brian L Odlaug.   

Abstract

BACKGROUND: Cannabis is the most widely used illicit substance and has been associated with cognitive impairment. It is unclear whether such impairment can occur in the absence of potential confounding influences of co-morbid axis-I disorders and use of other illicit substances.
METHOD: Young adult volunteers (18-29 years) were recruited from the general community on the basis of having no axis-I disorders or history of illicit substance use other than cannabis use. Subjects were then grouped according to presence or absence of cannabis use (>1 time/week over past 12 months). Cognition was compared between groups using selected paradigms from the CANTAB.
RESULTS: Cannabis users (N=16) and controls (N=214) did not differ significantly on salient demographic characteristics. Compared to controls, cannabis users showed significant impairments on quality of decision-making (Cambridge Gamble task), and executive planning (One Touch Stockings of Cambridge task). Response inhibition, spatial working memory, and sustained attention were intact.
CONCLUSIONS: This study identified cognitive deficits in cannabis users even in the absence of axis-I disorders and a history of using other illicit drugs. Future work should use longitudinal designs to track whether these deficits predate cannabis use or are due to its consumption.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21920674      PMCID: PMC3242860          DOI: 10.1016/j.drugalcdep.2011.08.015

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  37 in total

Review 1.  Adverse health effects of non-medical cannabis use.

Authors:  Wayne Hall; Louisa Degenhardt
Journal:  Lancet       Date:  2009-10-17       Impact factor: 79.321

Review 2.  Decision-making during gambling: an integration of cognitive and psychobiological approaches.

Authors:  Luke Clark
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-01-27       Impact factor: 6.237

Review 3.  [Cognitive abnormalities and cannabis use].

Authors:  Nadia Solowij; Nicole Pesa
Journal:  Braz J Psychiatry       Date:  2010-05       Impact factor: 2.697

4.  Decision making of heavy cannabis users on the Iowa Gambling Task: stronger association with THC of hair analysis than with personality traits of the Tridimensional Personality Questionnaire.

Authors:  Derik Hermann; Tagrid Leménager; Jan Gelbke; Helga Welzel; Gisela Skopp; Karl Mann
Journal:  Eur Addict Res       Date:  2009-01-10       Impact factor: 3.015

5.  Altered white matter microstructure in adolescent substance users.

Authors:  Sunita Bava; Lawrence R Frank; Tim McQueeny; Brian C Schweinsburg; Alecia D Schweinsburg; Susan F Tapert
Journal:  Psychiatry Res       Date:  2009-08-20       Impact factor: 3.222

6.  Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg delta-9-tetrahydrocannabinol (THC).

Authors:  Claudine C Hunault; Tjeert T Mensinga; Koen B E Böcker; C Maarten A Schipper; Maaike Kruidenier; Marianne E C Leenders; Irma de Vries; Jan Meulenbelt
Journal:  Psychopharmacology (Berl)       Date:  2008-12-20       Impact factor: 4.530

7.  Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.

Authors:  I Mata; J M Rodríguez-Sánchez; J M Pelayo-Terán; R Pérez-Iglesias; C González-Blanch; M Ramírez-Bonilla; O Martínez-García; J L Vázquez-Barquero; B Crespo-Facorro
Journal:  Psychol Med       Date:  2007-11-16       Impact factor: 7.723

8.  Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol.

Authors:  F Indlekofer; M Piechatzek; M Daamen; C Glasmacher; R Lieb; H Pfister; O Tucha; K W Lange; H U Wittchen; C G Schütz
Journal:  J Psychopharmacol       Date:  2008-07-17       Impact factor: 4.153

Review 9.  [Review: executive functioning and cannabis use].

Authors:  Priscila Previato Almeida; Maria Alice Fontes Pinto Novaes; Rodrigo Affonseca Bressan; Acioly Luiz Tavares de Lacerda
Journal:  Braz J Psychiatry       Date:  2008-03       Impact factor: 2.697

Review 10.  The neuropsychopharmacology of fronto-executive function: monoaminergic modulation.

Authors:  T W Robbins; A F T Arnsten
Journal:  Annu Rev Neurosci       Date:  2009       Impact factor: 12.449

View more
  52 in total

1.  Combined effects of HIV and marijuana use on neurocognitive functioning and immune status.

Authors:  April D Thames; Zanjbeel Mahmood; Alison C Burggren; Ahoo Karimian; Taylor P Kuhn
Journal:  AIDS Care       Date:  2015-12-23

2.  Impact of ADHD and cannabis use on executive functioning in young adults.

Authors:  Leanne Tamm; Jeffery N Epstein; Krista M Lisdahl; Brooke Molina; Susan Tapert; Stephen P Hinshaw; L Eugene Arnold; Katerina Velanova; Howard Abikoff; James M Swanson
Journal:  Drug Alcohol Depend       Date:  2013-08-11       Impact factor: 4.492

3.  BOLD responses to inhibition in cannabis-using adolescents and emerging adults after 2 weeks of monitored cannabis abstinence.

Authors:  Alexander L Wallace; Kristin E Maple; Alicia T Barr; Krista M Lisdahl
Journal:  Psychopharmacology (Berl)       Date:  2020-07-26       Impact factor: 4.530

4.  The moderating effects of cannabis use and decision making on the relationship between conduct disorder and risky sexual behavior.

Authors:  J Megan Ross; Stefany Coxe; Randi M Schuster; Angelica Rojas; Raul Gonzalez
Journal:  J Clin Exp Neuropsychol       Date:  2015-04-01       Impact factor: 2.475

5.  Effect of ageing on neurocognitive function by stage of HIV infection: evidence from the Multicenter AIDS Cohort Study.

Authors:  Karl Goodkin; Eric N Miller; Christopher Cox; Sandra Reynolds; James T Becker; Eileen Martin; Ola A Selnes; David G Ostrow; Ned C Sacktor
Journal:  Lancet HIV       Date:  2017-07-14       Impact factor: 12.767

Review 6.  Systematic review of ERP and fMRI studies investigating inhibitory control and error processing in people with substance dependence and behavioural addictions.

Authors:  Maartje Luijten; Marise W J Machielsen; Dick J Veltman; Robert Hester; Lieuwe de Haan; Ingmar H A Franken
Journal:  J Psychiatry Neurosci       Date:  2014-05       Impact factor: 6.186

Review 7.  The K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products.

Authors:  Lisa K Brents; Paul L Prather
Journal:  Drug Metab Rev       Date:  2013-09-24       Impact factor: 4.518

8.  Cannabis use and neurocognitive functioning in a non-clinical sample of users.

Authors:  April D Thames; Natalie Arbid; Philip Sayegh
Journal:  Addict Behav       Date:  2014-02-06       Impact factor: 3.913

9.  Lifetime cannabis use and cognition in patients with schizophrenia spectrum disorders and their unaffected siblings.

Authors:  Ana M Sánchez-Torres; Virginia Basterra; Araceli Rosa; Lourdes Fañanás; Amalia Zarzuela; Berta Ibáñez; Víctor Peralta; Manuel J Cuesta
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-04-12       Impact factor: 5.270

10.  Predictors of community functioning in schizophrenia and substance use disorder patients.

Authors:  Simon Zhornitsky; Ginette Aubin; Joelle Desfossés; Elie Rizkallah; Tania Pampoulova; Olivier Lipp; Jean-Pierre Chiasson; Emmanuel Stip; Stéphane Potvin
Journal:  Community Ment Health J       Date:  2012-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.